催產素市場 - 按適應症（產前、產後）、配銷通路（醫院藥房、零售藥房、線上藥房）- 全球預測（2024 - 2032）

Oxytocin Market - By Indication (Antepartum, Postpartum), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Global Forecast (2024 - 2032)

出版日期: 2024年04月29日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在老年人口快速成長的推動下，全球催產素市場規模預計 2024 年至 2032 年複合年成長率將達到 9.5%。研究人員正在探索催產素在傳統用途之外的擴展應用，以增強老年人的社會連結和情緒健康。透過不斷的探索，催產素在滿足老齡化社會不斷變化的需求方面發揮著重要作用，為支持老年人照護和福祉提供了新途徑。

正在進行的研究也推動了產品在老年保健領域的應用，以提供針對老齡化人口的特定挑戰的新穎治療方法。根據《2022年世界人口展望》，65歲以上人口的成長速度快於該年齡以下人口的成長速度。這一趨勢凸顯了催產素研究在滿足老齡化人口的特定需求方面日益重要。

整個市場分為適應症、配銷通路和地區。

就跡象而言，由於在身體準備分娩方面的作用日益增強，預計產前催產素產業從 2024 年到 2032 年將錄得顯著的複合年成長率。在懷孕期間，身體會自然產生催產素來刺激子宮收縮並促進分娩。因此，醫療保健提供者在必要時使用合成催產素來引產或增加分娩。此外，正在進行的研究正在試圖了解如何最佳化催產素的給藥以確保安全有效的引產和管理。

從配銷通路來看，線上藥局催產素產業預計將在 2024 年至 2032 年期間成長。這些平台還提供用於醫療目的的催產素，例如引產和產後出血的治療。隨著科技的進步，網路藥局正在改善醫療保健的可近性，特別是對於催產素等對孕產婦和生殖健康至關重要的藥物。

從地區來看，在輔助生殖應用不斷擴大和藥物傳遞方法進步的推動下，亞太地區催產素市場規模預計將在 2024 年至 2032 年間呈現強勁成長。該地區的醫療保健提供者正在利用催產素來提高生育治療的效果並有效地管理分娩。用於最佳化催產素給藥、提高其在生殖保健中的功效和安全性的給藥技術的持續進步將推動該產品在亞太地區的使用。

產業生態系統分析
產業影響力
- 成長動力
- 妊娠併發症發生率上升
- 生育率增加
- 人們對引產和母乳哺育的認知不斷提高
- 增加研發活動
- 產業陷阱與挑戰
- 嚴格的監管要求
- 藥費高
成長潛力分析
管道分析
監管環境
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按指標分類，2021 - 2032 年

主要趨勢
產前
產後

第 6 章：市場估計與預測：按配銷通路分類，2021 - 2032 年

主要趨勢
醫院藥房
零售藥局
網路藥局

第 7 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Endo International plc
Ferring Pharmaceuticals
Fresenius SE & Co. KGaA
Hikma Pharmaceuticals PLC
Novartis AG
Pfizer Inc.
Sun Pharma Industries Limited.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Wockhardt Limited
Yuhan Corporation

簡介目錄

Product Code: 9261

Global Oxytocin Market size is projected to record 9.5% CAGR from 2024 to 2032, driven by the rapid growth of the geriatric population. Researchers are exploring expanded applications of oxytocin beyond conventional uses for enhancing social bonding and emotional well-being among older adults. With this ongoing exploration, oxytocin is playing a significant role in meeting the evolving needs of the aging society for offering new avenues for supporting elderly care and well-being.

The ongoing research is also driving the product application in geriatric healthcare for providing novel therapeutic approaches tailored to specific challenges of the aging population. According to the World Population Prospects 2022, the population above the age of 65 years is growing more rapidly than the population below that age. This trend is underscoring the increasing relevance of oxytocin research in addressing the specific needs of the aging demographic.

The overall market is segregated into indication, distribution channel, and region.

In terms of indication, the oxytocin industry from the antepartum segment is expected to record significant CAGR from 2024 to 2032, driven by the increasing role in preparing the body for childbirth. During pregnancy, the body naturally produces oxytocin to stimulate uterine contractions and facilitate labor. Hence, healthcare providers are using synthetic oxytocin to induce or augment labor when necessary. In addition, ongoing studies are trying to understand how oxytocin administration can be optimized to ensure safe and effective labor induction and management.

By distribution channel, the oxytocin industry from the online pharmacies segment is projected to rise from 2024 to 2032. Online pharmacies offer oxytocin for providing convenient access for patients seeking the hormone. These platforms are also supplying oxytocin for medical purposes, such as labor induction and management of postpartum hemorrhage. With technological advances, online pharmacies are improving healthcare accessibility, especially for medications like oxytocin that are critical in maternal and reproductive health.

Regionally, the Asia Pacific oxytocin market size is projected to exhibit robust growth between 2024 and 2032, fueled by the expanding applications in assisted reproduction and advancements in drug delivery methods. Healthcare providers in the region are utilizing oxytocin to enhance outcomes in fertility treatments and manage labor effectively. The ongoing advancements in drug delivery technologies for optimizing the administration of oxytocin for improving its efficacy and safety profiles in reproductive health care will drive the product uptake in APAC.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Rising incidence of pregnancy complications
- 3.2.3 Increase in childbirth rates
- 3.2.4 Growing awareness of induced labor and breastfeeding
- 3.2.5 Increasing research & development activities
- 3.2.6 Industry pitfalls & challenges
- 3.2.7 Stringent regulatory requirements
- 3.2.8 High cost of drug
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Antepartum
5.3 Postpartum

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa